| Healing sound: the use of ultrasound in drug delivery and other therapeutic applications | 2005/03/01 | English | 664 |
| Cell cycle kinases as therapeutic targets for cancer | 2009/07/01 | English | 661 |
| Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms | 2005/11/24 | English | 654 |
| JAK inhibition as a therapeutic strategy for immune and inflammatory diseases | 2017/11/06 | English | 648 |
| The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment | 2013/12/13 | English | 648 |
| Advances in the development of new tuberculosis drugs and treatment regimens | 2013/04/30 | English | 646 |
| NK cells for cancer immunotherapy | 2020/01/06 | English | 645 |
| Mechanisms of drug combinations: interaction and network perspectives | 2009/02/01 | English | 639 |
| Ten years of anti-vascular endothelial growth factor therapy | 2016/01/18 | English | 627 |
| Hit and lead generation: beyond high-throughput screening | 2003/05/01 | English | 626 |
| Adenosine receptors as drug targets — what are the challenges? | 2013/03/28 | English | 626 |
| Optical biosensors in drug discovery | 2002/07/01 | English | 625 |
| From carbohydrate leads to glycomimetic drugs | 2009/07/24 | English | 616 |
| Drug development of MET inhibitors: targeting oncogene addiction and expedience | 2008/06/01 | English | 613 |
| Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond | 2006/01/20 | English | 611 |
| siRNAs: applications in functional genomics and potential as therapeutics | 2004/04/01 | English | 610 |
| Twenty years on: the impact of fragments on drug discovery | 2016/07/15 | English | 610 |
| Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter | 2015/04/07 | English | 603 |
| Microbubbles in medical imaging: current applications and future directions | 2004/06/01 | English | 603 |
| The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept | 2007/05/01 | English | 602 |
| Glycosylation as a strategy to improve antibody-based therapeutics | 2009/03/01 | English | 601 |
| Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders | 2008/05/01 | English | 601 |
| Teaching old receptors new tricks: biasing seven-transmembrane receptors | 2010/05/01 | English | 599 |
| Targeting IAP proteins for therapeutic intervention in cancer | 2012/02/01 | English | 596 |
| GSK3 inhibitors: development and therapeutic potential | 2004/06/01 | English | 596 |
| Potential therapeutic uses of BDNF in neurological and psychiatric disorders | 2011/03/01 | English | 596 |
| Tumour-initiating cells: challenges and opportunities for anticancer drug discovery | 2009/10/01 | English | 594 |
| Targeting Toll-like receptors: emerging therapeutics? | 2010/04/01 | English | 592 |
| ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges | 2020/01/03 | English | 592 |
| Predicting in vivo drug interactions from in vitro drug discovery data | 2005/10/01 | English | 590 |